Literature DB >> 9112853

Commentary: antenatal screening and targeting should be sufficient in some countries.

P P Mortimer1, E Miller.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9112853      PMCID： PMC2126434          DOI： 10.1136/bmj.314.7086.1036

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Overcoming barriers to hepatitis B immunisation by a dedicated hepatitis B immunisation service.

Authors:  V F Larcher; J Bourne; C Aitken; D Jeffries; D Hodes
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

2.  Developed countries could pay for hepatitis B vaccination in developing countries.

Authors:  N J Gay; W J Edmunds
Journal:  BMJ       Date:  1998-05-09

3.  The economic burden of hepatitis B in Germany.

Authors:  S Harbarth; T Szucs; K Berger; W Jilg
Journal:  Eur J Epidemiol       Date:  2000-02       Impact factor: 8.082

4.  Compliance with antenatal screening for hepatitis B surface antigen carrier status in pregnant women and consecutive procedures in exposed newborns.

Authors:  Kirsten Beckers; Urs B Schaad; Ulrich Heininger
Journal:  Eur J Pediatr       Date:  2004-08-17       Impact factor: 3.183
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.